Better understanding of T-cell lymphomas on the way
Haematologist Dr Paul Yeh is delighted to report a Cancer Council of Victoria (CCV) grant-in-aid has been awarded to him and his team to the value of $299,324. As a clinician-scientist and Head of Blood Cancer Biomarkers Laboratory, he is grateful for the support of CCV and is excited at the prospect of providing a better understanding of T-cell lymphomas. This research builds upon a successful clinical trial led by co-investigator Prof Jake Shortt that was recently completed at Monash Health. Additionally, the research will be conducted in collaboration with lead bioinformatician Dr Dineika Chandrananda at the Peter MacCallum Cancer Centre.
Says Dr Yeh, “This research aims to discover specific cancer signatures from a non-invasive blood test that can be used to monitor disease in a rare cancer called peripheral T-cell lymphoma (PTCL). With this information we aim to discover new biomarkers of response and resistance to therapy so we can inform the next phase of cancer therapeutic research.”
About Monash University
Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.
As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.
For more news, visit Medicine, Nursing and Health Sciences or Monash University.
MEDIA ENQUIRIES